Significant Ownership of STEMPOINT CAPITAL LP

Signature - Title
/s/ Sean C. Tan - Sean C. Tan, Authorized Signatory
Location
New York, NY
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by STEMPOINT CAPITAL LP.

Notify me when STEMPOINT CAPITAL LP files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of STEMPOINT CAPITAL LP

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
SRZN Surrozen, Inc. Common Stock, $0.0001 par value per share 11.4% $8,952,696 $3,926,731 1,016,197 +78% StemPoint Capital LP 30 Jun 2025
VTGN Vistagen Therapeutics, Inc Common Stock, par value $0.001 per share ("Shares") 8.2% $5,448,671 2,328,492 StemPoint Capital LP 31 Dec 2024
XLO Xilio Therapeutics, Inc. Common Stock, par value $0.0001 per share 7.2% $3,371,600 4,000,000 StemPoint Capital LP 30 Sep 2025

Schedules 13D/G Reported by STEMPOINT CAPITAL LP:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.